COST EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION VERSUS SURGICAL AORTIC VALVE REPLACEMENT- THE COREVALVE HIGH RISK TRIAL FROM A DUTCH PERSPECTIVE
Abstract
Authors
B.P. Geisler R.L. Osnabrugge S.A. Huygens M.J. Reardon A.P. Kappetein J.B. Pietzsch